These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9421559)

  • 21. Men's and women's knowledge and perceptions of breast cancer and mammography screening.
    Chamot E; Perneger TV
    Prev Med; 2002 Mar; 34(3):380-5. PubMed ID: 11902856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of health care, cost, and culture on breast cancer screening: issues facing urban American Indian women.
    Risendal B; Roe D; DeZapien J; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):501-9. PubMed ID: 10600431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What are the benefits and costs of screening mammograms on Kentucky women aged 40-49?
    Spratt JS; Gaines BM; Aaron WS; Cerrito P
    J Surg Oncol; 1996 Oct; 63(2):71-6. PubMed ID: 8888797
    [No Abstract]   [Full Text] [Related]  

  • 25. [Screening for breast cancer after the age of 70: effect on breast cancer mortality].
    van Dijck JA; Verbeek AL; Hendriks JH; Holland R
    Ned Tijdschr Geneeskd; 1995 Mar; 139(9):428-33. PubMed ID: 7891764
    [No Abstract]   [Full Text] [Related]  

  • 26. Characteristics of underserved women who did and those who did not use a free/low-cost voucher as part of a mammography screening program.
    Dole GF; Carney PA
    J Cancer Educ; 1998; 13(2):102-7. PubMed ID: 9659629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass screening programs for breast cancer in France--average values of assessment criteria.
    Lacour A; Mamelle N; Arnold F; Bazin B; Bohec C; Brégeault A; Chaperon J; Dubuc M; Duru G; Exbrayat C; Fontaine D; Manuel C; Obadia Y; Piette C; San Marco JL; Schaffer P; Trugeon A; Allemand H
    Cancer Detect Prev; 1997; 21(3):221-30. PubMed ID: 9167039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mammography screening as early detection measure. Pro].
    Koch MG
    Arch Gynecol Obstet; 1996; 259 Suppl 1():S161-77. PubMed ID: 9133270
    [No Abstract]   [Full Text] [Related]  

  • 29. American Cancer Society: Cost of screening mammography. Issues, recommendations, and solutions.
    Cancer; 1987 Oct; 60(7 Suppl):1694-9. PubMed ID: 3651997
    [No Abstract]   [Full Text] [Related]  

  • 30. International programs for the detection of breast cancer.
    Smith RA
    Salud Publica Mex; 2011; 53(5):394-404. PubMed ID: 22218793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs and cost-effectiveness of a church-based intervention to promote mammography screening.
    Stockdale SE; Keeler E; Duan N; Derose KP; Fox SA
    Health Serv Res; 2000 Dec; 35(5 Pt 1):1037-57. PubMed ID: 11130802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Offering mammography is beneficial in the long run].
    Cederblom S
    Lakartidningen; 1995 Dec; 92(51-52):4865-8. PubMed ID: 8544497
    [No Abstract]   [Full Text] [Related]  

  • 33. Breast cancer in Mexico: a growing challenge to health and the health system.
    Chávarri-Guerra Y; Villarreal-Garza C; Liedke PE; Knaul F; Mohar A; Finkelstein DM; Goss PE
    Lancet Oncol; 2012 Aug; 13(8):e335-43. PubMed ID: 22846838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reasons why women choose a medical practice or a women's health centre for routine health screening: worker and client perspectives.
    Peters K
    J Clin Nurs; 2010 Sep; 19(17-18):2557-64. PubMed ID: 20920081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammoscam.
    Randal J
    N C Med J; 1993 May; 54(5):194-5; discussion 196-9. PubMed ID: 8510774
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening mammography for women ages 40 to 49 years.
    Timins JK
    N J Med; 1997 Apr; 94(4):39-43. PubMed ID: 9108723
    [No Abstract]   [Full Text] [Related]  

  • 37. [Breast cancer screening and medical consumption].
    Riou F; Piette C; Evrard MY; Durand G; Bohec C; De Korvin B
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):333-40. PubMed ID: 11011300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammography in developing countries: the risks associated with globalizing the experiences of the Western world.
    Arslan AA; Formenti SC
    Nat Clin Pract Oncol; 2009 Mar; 6(3):136-7. PubMed ID: 19048009
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.
    Mackay J; Rogers C; Fielder H; Blamey R; Macmillan D; Boggis C; Brown J; Pharoah PD; Moss S; Day NE; Myles J; Austoker J; Gray J; Cuzick J; Duffy SW
    J Epidemiol Biostat; 2001; 6(5):365-9; discussion 371-5. PubMed ID: 11822726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for breast cancer and cost-effectiveness of thermal diagnostic techniques.
    Berger GS; Keith LG
    Prog Clin Biol Res; 1982; 107():839-49. PubMed ID: 6820147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.